Sanofi-aventis delivers a solid performance in third quarter 2009
- Details
- Category: Sanofi

Lilly CEO Lechleiter Calls for Repair of the 'Engine of Biopharma Innovation'
- Details
- Category: Eli Lilly and Company

Novartis on track to deliver Influenza A (H1N1) vaccine for the US
- Details
- Category: Novartis

Novel agent for treatment of Parkinson's disease - Lu 02-750
- Details
- Category: Lundbeck

Novo Nordisk increased operating profit by 30% in the first nine months of 2009
- Details
- Category: Novo Nordisk

-
Sales of modern insulins increased by 28% (24% in local currencies).
Sales of NovoSeven® increased by 15% (11% in local currencies).
Sales of Norditropin® increased by 15% (9% in local currencies).
Sales in North America increased by 29% (17% in local currencies).
Sales in International Operations increased by 18% (16% in local currencies).
AstraZeneca PLC Third Quarter & Nine Months Results 2009
- Details
- Category: AstraZeneca

Abbott completes acquisition acquisition of privately held eye care company Visiogen
- Details
- Category: Abbott

More Pharma News ...
- Forest Laboratories, Inc. and Gedeon Richter Announce Results from a Phase IIb Study of Cariprazine
- Pandemrix data in an elderly population
- Boehringer Ingelheim Animal Health closes deal to acquire Animal Health Business from Pfizer
- Novartis delivers strong new product momentum and operational performance
- Merck Revenues Increase by 2.7% to € 1.9 Billion
- FDA Determines VYVANSE® was Properly Granted Five-Year Market Exclusivity
- Sanofi-aventis and Wellstat Therapeutics enter into an Exclusive Worldwide Licensing Agreement